USX:STML - Stemline Therapeutics Inc Stemline Therapeutics, Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance Note: This stock seems to be inactive



Will Stemline Therapeutics (STML) Report Negative Q1 Earnings? What You Should Know

1 May 2020 - Yahoo News
Stemline Therapeutics (STML) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
usx:stml

What You Must Know About Stemline Therapeutics, Inc.'s (NASDAQ:STML) Beta Value

1 May 2020 - Yahoo News
If you're interested in Stemline Therapeutics, Inc. (NASDAQ:STML), then you might want to consider its beta (a measure...
usx:stml

Stemline Therapeutics, Inc. Just Reported, And Analysts Assigned A US$19.75 Price Target

17 Mar 2020 - Yahoo News
It's been a mediocre week for Stemline Therapeutics, Inc. (NASDAQ:STML) shareholders, with the stock dropping 19% to...
usx:stml

Edited Transcript of STML earnings conference call or presentation 16-Mar-20 12:00pm GMT

17 Mar 2020 - Yahoo News
Q4 2019 Stemline Therapeutics Inc Earnings Call
usx:stml

Stemline Therapeutics (STML) Reports Q4 Loss, Tops Revenue Estimates

13 Mar 2020 - Yahoo News
Stemline Therapeutics (STML) delivered earnings and revenue surprises of 2.56% and 0.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
usx:stml

Stemline Therapeutics Reports Fourth Quarter 2019 Financial Results

13 Mar 2020 - Yahoo News
Net revenue for ELZONRISĀ® was $11.8 million for the fourth quarterConference call and live webcast scheduled for Monday, March 16th, at 8:00 AM ET NEW YORK, March 13, 2020 --.
usx:stml

Stemline Therapeutics to Host Conference Call on Fourth Quarter 2019 Financial Results on March 16, 2020

11 Mar 2020 - Yahoo News
Stemline Therapeutics, Inc. (STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, today announced that the company will host a conference call and webcast on Monday, March 16, 2020 at 8:00 a.m. ET to report its fourth quarter ...
usx:stml

Stemline Therapeutics to Present at the Cowen 40th Annual Health Care Conference

26 Feb 2020 - Yahoo News
NEW YORK, Feb. 26, 2020 -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel.
usx:stml

STEMLINE THERAPEUTICS, INC. INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Stemline Therapeutics, Inc.

4 Feb 2020 - Yahoo News
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of shareholders of Stemline Therapeutics, Inc. (Nasdaq: STML) ("Stemline" or the "Company") resulting from allegations that Stemline Therapeutics, Inc. and/or its executives may ...
usx:stml

We're Hopeful That Stemline Therapeutics (NASDAQ:STML) Will Use Its Cash Wisely

20 Jan 2020 - Yahoo News
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
usx:stml

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms